Pepgen announces positive preclinical data for pgn-edo53, pgn-edo45 and pgn-edo44, three novel duchenne muscular dystrophy candidates

- in non-human primates (nhps), high levels of exon 53 skipping were observed after a single dose of pgn-edo53 – almost 7-times higher than those observed for a comparator peptide-phosphorodiamidate morpholino oligonucleotide (ppmo) conjugate molecule used as a positive control
PEPG Ratings Summary
PEPG Quant Ranking